Case report: Effect of antileishmanial treatment on hepatitis C viraemia in a visceral leishmaniasis patient with chronic hepatitis C

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 5, 2003, Pages 559-560

  Precone, David F ^a   Stornaiuolo, Gianfranca ^a   Galante, Domenico ^a   Amato, Anna ^a   Gradoni, Luigi ^b   Gaeta, Giovanni B ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Amphotericin B; Hepatitis C; Hepatocellular carcinoma; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTILEISHMANIAL AGENT; PROTOZOON ANTIBODY; VIRUS RNA; AMPHOTERICIN B; ANTIPROTOZOAL AGENT; LIPOSOME;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EXAMINATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DISEASE DURATION; ECHOGRAPHY; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; IMMUNOMODULATION; LEISHMANIA; LIVER CELL CARCINOMA; LIVER FUNCTION; MALE; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION; VISCERAL LEISHMANIASIS; LIVER TUMOR; MIDDLE AGED; VIREMIA; VIROLOGY;

HEPATITIS C VIRUS; PROTOZOA;

AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; CARCINOMA, HEPATOCELLULAR; HEPATITIS C, CHRONIC; HUMANS; LEISHMANIASIS, VISCERAL; LIPOSOMES; LIVER NEOPLASMS; MALE; MIDDLE AGED; VIRAL LOAD; VIREMIA;

EID: 7244224879     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)80028-7     Document Type: Article

References (16)

1. Arase Y. Ikeda K. Chayama K. Murashima N. Tsubota A. Suzuki Y. Saitoh S. Kobayashi M. Kobayashi M. Suzuki F. & Kumada H. Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C Journal of Gastroenterology 35 2000 221-225
2. Berhe N. Wolday D. Hailu A. Abraham Y. Ali A. Gebre-Michael T. Desjeux P. Sonnerborg A. Akuffo H. & Britton S. HIV viral load and response to antileishmanial chemotherapy in co-infected patients AIDS 13 1999 1921-1925
3. Bruix J. Sherman M. Llovet J.M. Beaugrand M. Lencioni R. Burroughs A.K. Christensen E. Pagliaro L. Colombo M. & Rodes J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. European Association for the Study of the Liver Journal of Hepatology 35 2001 421-430
4. Davidson R.N. Practical guide for the treatment of leishmaniasis Drugs 56 1998 1009-1018
5. Davidson R.N. di Martino L. Gradoni L. Giacchino R. Gaeta G.B. Pempinello R. Scotti S. Cascio A. Castagnola E. Maisto A. Gramiccia M. di Caprio D. Wilkinson R.J. Bryceson A.D. Shortcourse treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome) Clinical Infectious Diseases 22 1996 938-943
6. Desjeux P. The increase of risk factors for leishmaniasis worldwide Transactions of the Royal Society of Tropical Medicine and Hygiene 95 2001 239-243
7. Gaeta G.B. & Giusti G. Epidemiology of chronic viral hepatitis in the Mediterranean area: Present status and trends Infection 18 1990 21-25
8. Kamal S.M. Rasenack J.W. Bianchi L. Al Tawil A. El Sayed Khalifa K. Peter T. Mansour H. Ezzat W. & Koziel M. Acute hepatitis C without and with schistosomiasis: Correlation with hepatitis C-specific CD4(+) T-cell and cytokine response Gastroenterology 121 2001 646-656
9. Khaldi F. Bennaceur B. Ben Othman H. Achouri E. Ayachi R. & Regaieg R. Severe forms of liver involvement in visceral leishmaniasis Archives Francaises de Pediatric 47 1990 257-260
10. Kharazmi A. Kemp K. Ismail A. Gasim S. Gaafar A. Kurtzhals J.A. El Hassan A.M. Theander T.G. & Kemp M. T-cell response in human leishmaniasis Immunology Letters 65 1999 105-108
11. Nguyen T.T. Sedghi-Vaziri A. Wilkes L.B. Mondala T. Pockros P.J. Lindsay K.L. & McHutchison J.G. Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection Journal of Viral Hepatitis 3 1996 75-78
12. Pape G.R. Gerlach T.J. Diepolder H.M. Gruner N. Jung M. & Santantonio T. Role of the specific Tcell response for clearance and control of hepatitis C virus Journal of Viral Hepatitis 6 1999 36-40
13. Reyes E. Cardona J. Prieto A. Bernstein E.D. Rodriguez-Zapata M. Pontes M.J. & Alvarez-Mon M. Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells Journal of Infectious Diseases 181 2000 2003-2010
14. Rosen H.R. Miner C. Sasaki A.W. Lewinsohn D.M. Conrad A.J. Bakke A. Bouwer H.G. & Hinrichs D.J. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages Hepatology 35 2002 190-198
15. Suschek C.V. Bonmann E. Kapsokefalou A. Hemmrich K. Kleinert H. Forstermann U. Kroncke K.D. Mahotka C. & Kolb-Bachofen V. Revisiting an old antimicrobial drug: Amphotericin B induces interleukin-lconverting enzyme as the main factor for inducible nitricoxide synthaseexpression in activated endothelia Molecular Pharmacology 62 2002 936-946
16. Yeo A.E. Ghany M. Conry-Cantilena C. Melpolder J.C. Kleiner D.E. Shih J.W. Hoofnagle J.H. & Alter H.J. Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers Journal of Viral Hepatitis 8 2001 256-263